You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 11, June 8, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Treatment Adherence
 •Statistics and Research Methods
 •Prognosis/ Outcomes
 •Adherence
 •Adverse Effects
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Association Not Causation

Beatrice A. Golomb, MD, PhD; Sabrina Koperski

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the article by Shalev et al,1 the authors improperly draw causal inferences from observational connections between statin therapy compliance and survival. Historically, associations of drug use and compliance with favorable health outcomes can depart from causal findings, not only in magnitude but also in direction (recall the hormone therapy "data" on cardiac events and dementia).

Lower cognitive function (whether or not promoted by worse health)2-3 as well as lower conscientiousness3-4 portend both lower statin therapy compliance3 and greater mortality.2, 4 In addition, unfavorable health factors predict risk of statin adverse effects,5 which are in turn linked to noncompliance,6 and do so disproportionately with high-potency statins.5 This forges a further link between lower compliance and higher mortality that is statin specific—and greater with high-dose statin use—but not attributable to statin therapy benefits.5 Creatine phosphokinase and liver function test results are inadequate to exclude statin . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Continuation of Statin Treatment and All-Cause Mortality: A Population-Based Cohort Study
Varda Shalev, Gabriel Chodick, Haim Silber, Ehud Kokia, Joseph Jan, and Anthony D. Heymann
Arch Intern Med. 2009;169(3):260-268.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.